000 | 01647 a2200469 4500 | ||
---|---|---|---|
005 | 20250512023633.0 | ||
264 | 0 | _c19871112 | |
008 | 198711s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBeck, W T | |
245 | 0 | 0 |
_aPharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells. _h[electronic resource] |
260 |
_bCancer research _cOct 1987 |
||
300 |
_a5455-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B, Member 1 |
650 | 0 | 4 |
_aChloroquine _xtherapeutic use |
650 | 0 | 4 | _aChromosome Banding |
650 | 0 | 4 | _aChromosomes, Human, Pair 13 |
650 | 0 | 4 |
_aColchicine _xtherapeutic use |
650 | 0 | 4 |
_aDactinomycin _xtherapeutic use |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia _xdrug therapy |
650 | 0 | 4 |
_aMembrane Glycoproteins _xgenetics |
650 | 0 | 4 | _aMolecular Weight |
650 | 0 | 4 |
_aPodophyllotoxin _xtherapeutic use |
650 | 0 | 4 |
_aTeniposide _xtherapeutic use |
650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
650 | 0 | 4 |
_aVerapamil _xtherapeutic use |
650 | 0 | 4 |
_aVinblastine _xtherapeutic use |
650 | 0 | 4 |
_aVinca Alkaloids _xtherapeutic use |
700 | 1 | _aCirtain, M C | |
700 | 1 | _aDanks, M K | |
700 | 1 | _aFelsted, R L | |
700 | 1 | _aSafa, A R | |
700 | 1 | _aWolverton, J S | |
700 | 1 | _aSuttle, D P | |
700 | 1 | _aTrent, J M | |
773 | 0 |
_tCancer research _gvol. 47 _gno. 20 _gp. 5455-60 |
|
999 |
_c2894378 _d2894378 |